On Tuesday, Pacific Biosciences of California Inc (NASDAQ: PACB) opened lower -1.50% from the last session, before settling in for the closing price of $1.33. Price fluctuations for PACB have ranged from $1.16 to $3.89 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 16.73% annually for the last half of the decade. Company’s average yearly earnings per share was noted 33.69% at the time writing. With a float of $264.86 million, this company’s outstanding shares have now reached $294.42 million.
In an organization with 575 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 19.76%, operating margin of -265.64%, and the pretax margin is -200.98%.
Pacific Biosciences of California Inc (PACB) Insider Updates
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Pacific Biosciences of California Inc is 11.08%, while institutional ownership is 77.62%. The most recent insider transaction that took place on Mar 03 ’25, was worth 17,583. In this transaction an insider of this company sold 12,497 shares at a rate of $1.41, taking the stock ownership to the 2,225,357 shares. Before that another transaction happened on Mar 03 ’25, when Company’s insider sold 6,486 for $1.41, making the entire transaction worth $9,126. This insider now owns 1,497,695 shares in total.
Pacific Biosciences of California Inc (PACB) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 33.69% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.02% during the next five years compared to -23.55% drop over the previous five years of trading.
Pacific Biosciences of California Inc (NASDAQ: PACB) Trading Performance Indicators
Check out the current performance indicators for Pacific Biosciences of California Inc (PACB). In the past quarter, the stock posted a quick ratio of 6.59. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.62, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.62 in one year’s time.
Technical Analysis of Pacific Biosciences of California Inc (PACB)
Let’s dig in a bit further. During the last 5-days, its volume was 6.18 million. That was inferior than the volume of 11.5 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 64.51%. Additionally, its Average True Range was 0.12.
During the past 100 days, Pacific Biosciences of California Inc’s (PACB) raw stochastic average was set at 8.44%, which indicates a significant decrease from 44.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.51% in the past 14 days, which was lower than the 98.85% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5044, while its 200-day Moving Average is $1.7194. However, in the short run, Pacific Biosciences of California Inc’s stock first resistance to watch stands at $1.3367. Second resistance stands at $1.3633. The third major resistance level sits at $1.3867. If the price goes on to break the first support level at $1.2867, it is likely to go to the next support level at $1.2633. Assuming the price breaks the second support level, the third support level stands at $1.2367.
Pacific Biosciences of California Inc (NASDAQ: PACB) Key Stats
There are currently 297,852K shares outstanding in the company with a market cap of 390.19 million. Presently, the company’s annual sales total 154,010 K according to its annual income of -309,850 K. Last quarter, the company’s sales amounted to 39,220 K and its income totaled 2,370 K.
